Showing results (41-50 of 653) with videos related to
Sort By:
Pageof 66
Managed Care (Langhorne, Pa.)|June 30, 2017
Chimeric Antigen Receptor T-Cell Therapy: The Next Big Thing Faces ChallengesJack McCainManaged Care (Langhorne, Pa.)|May 7, 1996
The corporate practice of health care ... a panel discussionM J Calhoun, M Collins, M Hasan, et al.Managed Care (Langhorne, Pa.)|September 5, 1995
Will state licensing boards become managed care's police?M KassbergManaged Care (Langhorne, Pa.)|August 10, 2001
HMOs need to share gains of DM programs. Physician are more likely to buy in if they see better outcomes--and financial rewards that go with themH L LeiderManaged Care (Langhorne, Pa.)|January 5, 2002
Successful management of lipid-lowering programsA T WrightManaged Care (Langhorne, Pa.)|November 1, 2007
Comparison of human growth hormone products' cost in pediatric and adult patients. A budgetary impact modelGary R Bazalo, Ashish V Joshi, John GermakManaged Care (Langhorne, Pa.)|November 3, 2011
Immunotherapy for advanced prostate cancer: a novel treatment option to improve survivalSteven R PeskinManaged Care (Langhorne, Pa.)|September 6, 2011
Outcomes and costs associated with initial maintenance therapy with fluticasone propionate-salmeterol xinafoate 250 microg/50 microg combination versus tiotropium in commercially insured patients with COPDAnand A Dalal, Sean D Candrilli, Keith L DavisManaged Care (Langhorne, Pa.)|February 16, 2012
Treatment persistence & health care costs of adult MDD patients treated with escitalopram vs. citalopram in a medicaid populationEric Q Wu, Rym Ben-Hamadi, Mei Lu, et al.Managed Care (Langhorne, Pa.)|August 25, 2018
Forget the Pills. Healthy Food Is the PrescriptionTimothy KelleyPageof 66